Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04YAK
|
|||
| Former ID |
DIB003487
|
|||
| Drug Name |
MPC-2130
|
|||
| Synonyms |
MPC-176716; MPI-176716
Click to Show/Hide
|
|||
| Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Phase 1 | [1] | |
| Company |
Myriad Genetics Inc
|
|||
| Structure |
 |
Download2D MOL |
||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT00387153) Phase 1 Clinical Trial MPC-2130 Treatment of Blood Cancers / Refractory Cancer. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.